Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
复制标题
DOI：
10.1016/j.canep.2022.102313
复制
发表时间：
2023-02
影响因子：
2.6
通讯作者：
Takahashi, Hirokazu
中科院分区：
文献类型：
--
作者：
Machii, Ryoko;Takahashi, Hirokazu
关键词：
2019冠状病毒病（COVID-19）大流行对参与癌症筛查的影响是一个全球关注的问题。日本有一个筛查表现的国家数据库，用于基于人群的癌症筛查，估计覆盖所有癌症筛查的大约一半。利用2017-2020财政年度（FY）国家数据库，确定胃癌（上胃肠道[UGI]系列或内窥镜检查）、结直肠癌（粪便隐血检查）、肺癌（胸部x光检查）、乳腺癌（乳房x光检查）和宫颈癌（巴氏涂片检查）筛查的参与者人数。计算参与者人数变化的百分比。与大流行前时期（2017-2019财年）相比，从百分比来看，2020财年胃癌UGI系列下降幅度最大（282万至191万，变化幅度为- 32.2%），其次是乳腺癌筛查（310万至257万，变化幅度为- 17.2%）、肺癌筛查（792万至659万，变化幅度为- 16.7%）、结直肠癌筛查（842万至730万，变化幅度为- 13.4%）、宫颈癌筛查(426万至377万，百分比变化为- 11.6%)，内镜下胃癌（102万至93万，百分比变化为- 9.0%）。在大流行期间，日本参加基于人群的筛查的人数减少了约10 - 30%。应仔细监测这些下降对癌症检测或死亡率的影响。
The impact of the coronavirus disease 2019 (COVID-19) pandemic on cancer screening participation is a global concern. A national database of screening performance is available in Japan for population-based cancer screening, estimated to cover approximately half of all cancer screenings. Utilizing the fiscal year (FY) 2017–2020 national database, the number of participants in screenings for gastric cancer (upper gastrointestinal [UGI] series or endoscopy), colorectal cancer (fecal occult blood test), lung cancer (chest X-ray), breast cancer (mammography), and cervical cancer (Pap smear) were identified. The percent change in the number of participants was calculated. Compared with the pre-pandemic period (FY 2017–2019), in percentage terms FY 2020 recorded the largest decline in gastric cancer UGI series (2.82 million to 1.91 million, percent change was −32.2 %), followed by screening for breast cancer (3.10 million to 2.57 million, percent change was −17.2 %), lung cancer (7.92 million to 6.59 million, percent change was −16.7 %), colorectal cancer (8.42 million to 7.30 million, percent change was −13.4 %), cervical cancer (4.26 million to 3.77 million, percent change was −11.6 %), and gastric cancer via endoscopy (1.02 million to 0.93 million, percent change was −9.0 %). The number of participants in population-based screenings in Japan decreased by approximately 10–30 % during the pandemic. The impact of these declines on cancer detection or mortality should be carefully monitored.
影响因子：
28.4
作者：
Chen, Ronald C.;Haynes, Kevin;Katz, Aaron J.
通讯作者：
Katz, Aaron J.
影响因子：
2.4
作者：
Okuyama, Ayako;Watabe, Mari;Higashi, Takahiro
通讯作者：
Higashi, Takahiro
影响因子：
8.8
作者：
Gathani T;Clayton G;MacInnes E;Horgan K
通讯作者：
Horgan K